Seven Grand Managers LLC Makes New $4.41 Million Investment in Sotera Health Company $SHC

Seven Grand Managers LLC purchased a new position in Sotera Health Company (NASDAQ:SHC) during the 4th quarter, HoldingsChannel.com reports. The firm purchased 250,000 shares of the company’s stock, valued at approximately $4,410,000.

Other hedge funds have also recently added to or reduced their stakes in the company. IFP Advisors Inc grew its position in Sotera Health by 1,105.6% in the fourth quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock worth $26,000 after buying an additional 1,371 shares during the last quarter. True Wealth Design LLC grew its position in Sotera Health by 389.3% during the 4th quarter. True Wealth Design LLC now owns 1,830 shares of the company’s stock worth $32,000 after purchasing an additional 1,456 shares in the last quarter. Allworth Financial LP grew its position in Sotera Health by 922.0% during the 4th quarter. Allworth Financial LP now owns 3,025 shares of the company’s stock worth $53,000 after purchasing an additional 2,729 shares in the last quarter. EverSource Wealth Advisors LLC grew its position in Sotera Health by 831.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock worth $37,000 after purchasing an additional 2,935 shares in the last quarter. Finally, GAMMA Investing LLC grew its position in Sotera Health by 31.1% during the 4th quarter. GAMMA Investing LLC now owns 4,892 shares of the company’s stock worth $86,000 after purchasing an additional 1,161 shares in the last quarter. Institutional investors and hedge funds own 91.03% of the company’s stock.

Sotera Health Trading Down 2.6%

Shares of NASDAQ:SHC opened at $15.54 on Thursday. The firm has a fifty day moving average of $15.12 and a two-hundred day moving average of $16.38. The firm has a market capitalization of $4.43 billion, a P/E ratio of 37.90 and a beta of 1.82. Sotera Health Company has a 12-month low of $10.80 and a 12-month high of $19.85. The company has a quick ratio of 2.54, a current ratio of 2.82 and a debt-to-equity ratio of 3.56.

Sotera Health (NASDAQ:SHC) last issued its earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. The company had revenue of $280.05 million during the quarter, compared to analyst estimates of $270.78 million. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. The company’s revenue for the quarter was up 10.0% on a year-over-year basis. During the same quarter last year, the business posted $0.14 EPS. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. On average, equities analysts expect that Sotera Health Company will post 0.86 EPS for the current fiscal year.

Insider Activity

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of Sotera Health stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total transaction of $193,194,516.17. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 15.36% of the stock is owned by company insiders.

Analyst Ratings Changes

Several research firms have weighed in on SHC. Zacks Research cut shares of Sotera Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 30th. Barclays lowered their price objective on shares of Sotera Health from $20.00 to $18.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. Citigroup lifted their price objective on shares of Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a research report on Tuesday, February 24th. Wall Street Zen cut shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, April 11th. Finally, Weiss Ratings cut shares of Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a research report on Thursday, May 21st. Seven research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, Sotera Health has an average rating of “Moderate Buy” and a consensus target price of $20.33.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.